Ryan Martins

Ryan Martins

Director Financiero/CFO en 89BIO, INC. .
49 años
Health Technology
Finance
Consumer Services

Perfil

Ryan Stephen Martins is currently Chief Financial Officer at 89bio, Inc., a position held since 2019.
Formerly, Mr. Martins was Chief Financial Officer at Revolution Medicines, Inc. in 2018; VP-Corporate Strategy & Investor Relations at Ultragenyx Pharmaceutical, Inc. from 2015 to 2018; Senior Biotechnology Analyst at Jefferies LLC from 2014 to 2015; Senior Biotechnology Analyst at FM Partners Holdings LLC from 2013 to 2014; Vice President at Barclays Capital, Inc. from 2008 to 2011; Associate at Lehman Brothers, Inc. from 2006 to 2008; Principal at Chiron Corp.
in 2006.
Education includes degrees from Virginia Polytechnic Institute & State University (graduate, 2001), the University of Mumbai (undergraduate and graduate), Haas School of Business (MBA), and St. Xavier's College (undergraduate).

Cargos activos de Ryan Martins

EmpresasCargoInicio
89BIO, INC. Director Financiero/CFO 01/07/2019

Antiguos cargos conocidos de Ryan Martins.

EmpresasCargoFin
REVOLUTION MEDICINES, INC. Director Financiero/CFO 01/10/2018
ULTRAGENYX PHARMACEUTICAL INC. Contacto de Relaciones con Inversores 01/03/2018
Analyst-Equity 01/07/2015
Analyst-Equity 31/01/2014
Analyst-Equity -
Ver el detalle de la experiencia de Ryan Martins.

Formación de Ryan Martins.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

98

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas12

Health Technology

Finance

Health Technology

Finance

Finance

Finance

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology